Ren Jing Yi

Fellow(FESC)、 (AHS) 、 (ISHR) 、 、 、 、 、 、 、 、《FrontiersCardiovascularMedicine》ReviewEditor、《 》、《 》、《 》.: 、 、;..:2001,;2003,;2006,;2009~2010 / GöranK.Hansson.:2006~2015, 、 、 、; 、.2015 ~,;2016 ~2024,;2017 ~,;2018 ~,;2021 ~, 、;2024 ~,.: 、 、 、 “ ”、 、 、 、 、 、 、 、. 17. ACSSens.、Heart.、ClinEpigenetics. SCI 40.: 、,, “ ”, 8 、 23. “ ”、“ ”、“ ”、“ ”. 《 》、《 》、《 》、《 》、《 》. 《 》 《 》. “ ”、“ ”、“ ”、“ ”.: “ ”、 “ ”、 “ ” 、 “ ” 、 “ · ” 、. 《 》“ · ”. “ ”、 “ ”、“ ”、“ ”、“ ”、“ ”; 、 、.: 1.:;2024-2028 2.:;2022-2026 3. “ ”:;2024-2027 4. (H ):;2024-2026 5.: 3D netrin-1;2018-2021 6.:Lp-PLA2;2013-2016 7.: A2;2009-2010 8.:“ + ”;2024-2027 9. -:;2025-2029 10.:;2022-2025 11.:;2022-2024 12.:;2022-2025 13.:“ ”;2022-2025 14.::2023-2025 15.:;2022-2024 16.:;2020-2021 17.: -microRNAs;2015-2016 18.: DNA;2022-2023 19.:HFpEF;2021-2021 20.:;2020-2020 21.:cetp;2017-2018: ACSSens.、Heart.、ClinEpigenetics. SCI 40. 3: 1.Gapsinknowledgeandmanagementofirondeficiencyinheartfailure:anationwidesurveyofcardiologistsinChina.Heart.2025Apr10;111(9):421-429. 2.Efficacyandsafetyofroxadustatfortreatinganaemiainpatientswithchronickidneydiseaseandheartfailure:aretrospectivecohortstudy.ClinKidneyJ.2025Feb24;18(4):sfaf061. 3.Cardiaccontractilitymodulationtoenhanceoptimizedmedicaltherapyandimprovecardiacremodelinginadvancedheartfailure:acasereport.FrontCardiovascMed.2025Jun6;12:1577680. 4.Correlationanalysisofhematocritlevelandcoronaryheartdiseaseinpatientswithchestpain:acase-controlstudy.JThoracDis.2025Apr30;17(4):2492-2502. 5.SHengXIaN-QuYuDEcoctionintheTreatmentofHeartFailurewithReducedandMildly-ReducedEjectionFraction(SHINE-HF):rationaleanddesignforamulticenterrandomizedcontrolledtrial.ContempClinTrialsCommun.2025May22;45:101497. 6.ConstructionofaNear-InfraredFluorescentProbeforDynamicMonitoringandEarlyDiagnosisofHeartFailure.ACSSens.2024Jun28;9(6):3075-3084. 7.DesignandrationaleoftheATTRACTIVEtrial:arandomisedtrialofintrAThrombusThrombolysisversusaspiRAtionthrombeCTomyduringprImarypercutaneouscoronaryinterVEntioninST-segmentelevationmyocardialinfarctionpatientswithhighthrombusburden.BMJOpen.2023Nov10;13(11):e076476. 8.Thepredictionofin-hospitalmortalityinchronickidneydiseasepatientswithcoronaryarterydiseaseusingmachinelearningmodels.EurJMedRes.2023Jan18;28(1):33. 9.EvaluatingthepredictivevalueofdiabetesmellitusdiagnosedaccordingtotheChineseguidelines(2020edition)forcardiovascularevents.DiabetolMetabSyndr.2022Sep26;14(1):138. 10.CognitiveImpairmentinHeartFailure:Landscape,Challenges,andFutureDirections.FrontCardiovascMed.2022Feb7;8:831734. 11.BloodGroupOProtectEnd-StageRenalDiseasePatientsWithDialysisFromCoronaryArteryDisease.FrontCardiovascMed.2022Jan28;8:821540. 12.PredictiveValueoftheCHA2DS2-VAScScoreforMortalityinHospitalizedAcuteCoronarySyndromePatientsWithChronicKidneyDisease.FrontCardiovascMed.2022Mar16;9:790193. 13.Triglycerideglucoseindexexacerbatestheriskoffuturecardiovasculardiseaseduetodiabetes:evidencefromtheChinaHealthandRetirementLongitudinalSurvey(CHARLS).BMCCardiovascDisord.2022May21;22(1):236.: 、